Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | XBP1 | P17861 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HBB | P68871 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12869405 | 0.77 | CASP3 (0.31) | MAPT | |
| SCHEMBL12748809 | 0.76 | NPC1 (0.31) | NPC1ALDH1A1LMNATP53POLB | |
| SCHEMBL3621290 | 0.74 | TNF (0.34) | NPC1ALDH1A1LMNATP53POLB | |
| SCHEMBL9290439 | 0.69 | ALDH1A1 (0.42) | NPC1ALDH1A1LMNAMAPK1HTT | |
| SCHEMBL12748800 | 0.68 | ANPEP (0.33) | — | |
| SCHEMBL14946823 | 0.68 | — | — | |
| SCHEMBL14946825 | 0.64 | ANPEP (0.31) | — | |
| SCHEMBL12107612 | 0.63 | ALDH1A1 (0.38) | NPC1ALDH1A1LMNATP53POLB | |
| SCHEMBL16419897 | 0.62 | ANPEP (0.41) | — | |
| SCHEMBL7938900 | 0.62 | MEN1 (0.32) | ALDH1A1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8350054-B2 | Optical filter | ADEKA CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| US-8350054-B2 | Optical filter | ADEKA CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| EP-2458941-A1 | OPTICAL FILTER | Adeka Corporation (JP) | 2012-05-30 | — | — | EP | disclosed |
| US-20110152538-A1 | OPTICAL FILTER | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
| US-20110152538-A1 | OPTICAL FILTER | ADEKA CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152538-A1 | OPTICAL FILTER | C1R, CBR3, CBR1 | NPC1 1537/4885ALDH1A1 776/4885LMNA 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.